Jessica Morris Edgar's Insider Trades & SAST Disclosures
Jessica Morris Edgar's most recent trade in Tonix Pharmaceuticals Holding Corp was a trade of 29,291 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jessica Morris Edgar.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 29,291 | 29,291 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 29,291 | 29,291 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 05 Feb 2025 | 1 | 0 (0%) | 0% | 0 | Common Stock, $0.001 par value | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 317,000 | 317,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Morris Edgar | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 317,000 | 317,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 207,500 | 207,500 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 207,500 | 207,500 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,100,000 | 1,100,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,100,000 | 1,100,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,100,000 | 1,100,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,100,000 | 1,100,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 540,000 | 540,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 540,000 | 540,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2020 | 360,000 | 360,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Jessica Edgar Morris | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2020 | 360,000 | 360,000 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges